Due to a fruitful collaboration within INCIP, under the umbrella of ESGO, we were able to investigate data on 1170 patients with cancer in pregancy, over a period of 20 years.
In the last 20 years more women were treated during pregnancy, especifically with chemotherapy. There appears to be a link between chemotherapy during pregnancy and a too small baby, but we also see a decrease in the number of premature births.
For more than a decade, the International Network on Cancer, Infertility and Pregnancy has been leading an innovative research project in the treatment of cancer in pregnant women. We are glad to share out findings in this new Textbook Cancer in Pregnancy and hope that the information can be clinically useful for colleagues over the world.
During the closing ceremony of the ESGO congress in Vienna, dr. ir. Liesbeth Lenaerts, received a certificate for Best Oral Presentation.
As a postdoctoral researcher within INCIP and KU Leuven, she is working on 'Sensitivity of non-invasive prenatal test for cancer detection and treatment monitoring, in pregnant women'.
Recently we received a KWF grant (Dutch Cancer Society) to further expand the research on Post Partum Breast Cancer.
Brief description of this research:
A heartwarming ending of 2016! Thanks to one of the grants from KWF (Dutch Cancer Society), Frédéric Amant is able to further expand the research on Cancer and Pregnancy in The Netherlands.
The grant was awarded for his CRADLE Project: Cancer tReAtment During pregnancy: from fetaL to maternal safety Efficacy. We thank all volunteers of the KWF Dutch Cancer Society.
In 2015, the ESGO Taskforce on Cancer in Pregnancy has been transformed to the International Network on Cancer, Infertility and Pregnancy (INCIP). With this transformation, a rapidly growing number of the members and with that the fields of experience.
The press release at European Cancer Congress in Vienna on the New England Journal of Medicine paper “
The INCIP group was asked to give its expert opinion in The ASCO Post on the article ‘Ovarian Suppression During Chemotherapy Preserves Fertility in Young Women With Breast Cancer’.